Literature DB >> 24810978

Effects of policy changes to universal newborn hearing screening follow-up in a university clinic.

Lata A Krishnan, Shannon Van Hyfte.   

Abstract

PURPOSE: The purpose of this study was to evaluate the effects of policy changes on loss to follow-up rates and the ability to achieve the goals of the American Academy of Pediatrics Joint Committee on Infant Hearing Screening (2007) for diagnosis of hearing loss by 3 months, amplification within 1 month of diagnosis, and start of intervention by 6 months.
METHOD: From the files of 111 infants, data were extracted on the following: date of birth, birth hospital, hometown, parents' ages, ethnicity, nursery status, medical history, age at initial evaluation and diagnosis, results of evaluation(s), and age at hearing aid fitting and start of early intervention. Data were compared with previously published data from the clinic (Krishnan, 2009).
RESULTS: Policy changes led to a decrease in loss to follow-up and a younger age at diagnosis of hearing loss. Infants identified with hearing loss were fit with amplification at younger ages but not within 1 month of diagnosis of hearing loss. Policy changes had positive outcomes on loss to follow-up and age of diagnosis and amplification.
CONCLUSIONS: Challenges remain in meeting the goals of amplification within 1 month of diagnosis and documenting the start of early intervention. Improved communication between and education of all parties involved in the care of infants is needed.

Entities:  

Mesh:

Year:  2014        PMID: 24810978     DOI: 10.1044/2014_AJA-14-0008

Source DB:  PubMed          Journal:  Am J Audiol        ISSN: 1059-0889            Impact factor:   1.493


  1 in total

1.  Home-based Early Intervention on Auditory and Speech Development in Mandarin-speaking Deaf Infants and Toddlers with Chronological Aged 7-24 Months.

Authors:  Ying Yang; Yue-Hui Liu; Ming-Fu Fu; Chun-Lin Li; Li-Yan Wang; Qi Wang; Xi-Bin Sun
Journal:  Chin Med J (Engl)       Date:  2015-08-20       Impact factor: 2.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.